4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-013210
Chief Executive Officer sold 51,425 shares at $15.07 ($774,975)
- Chief Executive Officer acquired 340,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2025-03-13 | Grant or award | +340,000 | 4,113,802 | D | ||
| Anzalone Christopher Richard Chief Executive Officer | 2025-03-13 | Sale | −51,425 | $15.07 | $774,975 | 4,062,377 | D |
| Open-market sales · 51,425 sh · avg $15.07 · $774,975 | |||||||
Loading xslF345X05/wk-form4_1742247926.xml…